Literature DB >> 7272941

Flow cytometry of breast carcinoma: II. Relation of tumor cell cycle distribution to histology and estrogen receptor.

W Olszewski, Z Darzynkiewicz, P P Rosen, M K Schwartz, M R Melamed.   

Abstract

Flow cytometry analysis of cell cycle distribution was carried out on acridine-orange-stained cell suspensions freshly prepared from carcinoma of the breast of 90 women, and compared with control, benign breast specimens from 10 women. There was a significantly greater proportion of cells in S (9.1% +/- 5.8) and G2 + M (8.0 +/- 6.0) phases of the cycle in breast cancer specimens than in the S (1.5% +/- 0.6) and G2 + M (2.5 +/- 0.9) phases of the cycle in benign, control specimens of breast tissue. Great variation was noted among the breast cancers, with medullary carcinomas having the highest percentage of cells in S + G2 + M, and papillary, tubular, colloid and well-differentiated duct carcinomas having the lowest. Tumors from premenopausal women classified as estrogen receptor negative had significantly more cells in S + G2 + M than did tumors from postmenopausal women that were estrogen-receptor positive.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7272941     DOI: 10.1002/1097-0142(19810815)48:4<985::aid-cncr2820480422>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

Review 1.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

Review 2.  The prognostic value of flow cytometric DNA analysis in colorectal cancer patients.

Authors:  H Suzuki
Journal:  Jpn J Surg       Date:  1988-09

3.  DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.

Authors:  T Yokoe; M Izuo; T Ishida; Y Iino; T Kawai
Journal:  Jpn J Surg       Date:  1990-09

4.  Mitotic rate, DNA distribution, and chromatin in situ sensitivity to heparin in breast cancer.

Authors:  H Weiss; H P Brasching; A Bock; F Mauthner; U Peek
Journal:  Breast Cancer Res Treat       Date:  1990-07       Impact factor: 4.872

5.  Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer.

Authors:  T E Kute; H B Muss; M Hopkins; R Marshall; D Case; L Kammire
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 6.  Practical breast carcinoma cell kinetics: review and update.

Authors:  J S Meyer; R W McDivitt; K R Stone; M U Prey; W C Bauer
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

7.  Nuclear DNA content and prognosis in human breast cancer: a static cytophotometric study.

Authors:  J Harvey; N de Klerk; I Berryman; G Sterrett; M Byrne; J Papadimitriou
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

8.  DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.

Authors:  L Pedersen; J K Larsen; I J Christensen; A Lykkesfeldt; S Holck; T Schiødt
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Nuclear DNA content in breast carcinoma with special reference to the parameters of malignant potentiality.

Authors:  S Suehiro; Y Hamada; M Toi; T Nakamura; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1990-01

10.  Ki-67 reactivity in breast carcinoma analyzed by a computer-assisted image system: preliminary results.

Authors:  R Mir; H Johnson; R Mathur; L Wise; L B Kahn
Journal:  J Natl Med Assoc       Date:  1995-08       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.